Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products
International Journal of Environmental Research and Public Health · 10.02.2026 · 23 (2) · 224
DOI: 10.3390/ijerph23020224 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 10.02.2026. Verfasst von Luiza Rosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA. Hauptthemen laut MEDLINE: Cannabidiol, Anxiety, Dronabinol, Cannabis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Drug Abuse (NIDA).
Abstract (Originalsprache)
Research shows that delta-9-tetrahydrocannabinol (THC) is linked to increased anxiety, while cannabidiol (CBD) may have anxiolytic effects. Cannabis use is often driven by coping with anxiety, though its daily impact on anxiety remains unclear. This study examined daily associations between cannabis use and anxiety across 30 days in adults who wanted to use cannabis for anxiety relief. Participants (N = 345) used flower or edible products ad libitum and were randomly assigned to groups by product type (CBD, THC, or THC + CBD). Each day, participants reported cannabis use in the past 24 h and rated their anxiety. Linear mixed-effects models tested whether anxiety changed over time, differed by cannabinoid group, and varied with use. Anxiety significantly decreased over the study period in both flower and edibles groups. In the flower group, THC + CBD and CBD products had greater decreases in anxiety (39.5% and 34.8%, respectively) compared to THC products (7.8%). In the edibles group, when participants used CBD products, this was associated with a 24.9% reduction in anxiety over the 30 days. Findings underscore the importance of distinguishing cannabis effects by product type and cannabinoid composition and suggest that CBD-dominant edibles were associated with less anxiety over time in this naturalistic study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA.
- Institute of Cognitive Science, University of Colorado Boulder, Boulder, CO 80309, USA.
ORCID-Profile: Luiza Rosa, Jonathon K Lisano, Carillon J Skrzynski, L Cinnamon Bidwell
Förderung
- National Institute on Drug Abuse (NIDA)
Zitieren
APA
Rosa, L., Lisano, J. K., Skrzynski, C. J., Bryan, A. D., & Bidwell, L. C. (2026). Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products. International Journal of Environmental Research and Public Health, 23(2), 224. https://doi.org/10.3390/ijerph23020224
Vancouver
Rosa L, Lisano JK, Skrzynski CJ, Bryan AD, Bidwell LC. Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products. International Journal of Environmental Research and Public Health. 2026;23(2):224. doi:10.3390/ijerph23020224
BibTeX
@article{Rosa2026,
author = {Rosa, Luiza and Lisano, Jonathon K and Skrzynski, Carillon J and Bryan, Angela D and Bidwell, L Cinnamon},
title = {Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products},
journal = {International Journal of Environmental Research and Public Health},
year = {2026},
volume = {23},
number = {2},
pages = {224},
doi = {10.3390/ijerph23020224}
}
EUVIMED